Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Colorcon
Chubb
Fuji
Daiichi Sankyo
US Army
Baxter
McKesson
Deloitte

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060385

« Back to Dashboard

NDA 060385 describes NEOMYCIN SULFATE, which is a drug marketed by Breckenridge Pharm, Bristol Myers Squibb, Lannett, Lannett Holdings Inc, Lilly, Roxane, Sandoz, Teva, X Gen Pharms, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the NEOMYCIN SULFATE profile page.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for 060385
Tradename:NEOMYCIN SULFATE
Applicant:Lilly
Ingredient:neomycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 060385

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo
Cipla
Queensland Health
Harvard Business School
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot